Literature DB >> 26663518

Early Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment.

H M Wadei1, D D Lee1, K P Croome1, M L Mai1, E Golan1, R Brotman1, A P Keaveny1, C B Taner1.   

Abstract

Early allograft dysfunction (EAD) after liver transplantation (LT) is related to ischemia-reperfusion injury and may lead to a systemic inflammatory response and extrahepatic organ dysfunction. We evaluated the effect of EAD on new-onset acute kidney injury (AKI) requiring renal replacement therapy within the first month and end-stage renal disease (ESRD) within the first year post-LT in 1325 primary LT recipients. EAD developed in 358 (27%) of recipients. Seventy-one (5.6%) recipients developed AKI and 38 (2.9%) developed ESRD. Compared with those without EAD, recipients with EAD had a higher risk of AKI and ESRD (4% vs. 9% and 2% vs. 6%, respectively, p < 0.001 for both). Multivariate logistic regression analysis showed an independent relationship between EAD and AKI as well as ESRD (odds ratio 3.5, 95% confidence interval 1.9-6.4, and odds ratio 3.1, 95% confidence interval 11.9-91.2, respectively). Patients who experienced both EAD and AKI had inferior 1-, 3-, 5-, and 10-year patient and graft survival compared with those with either EAD or AKI alone, while those who had neither AKI nor EAD had the best outcomes (p < 0.001). Post-LT EAD is a risk factor for both AKI and ESRD and should be considered a target for future intervention to reduce post-LT short- and long-term renal dysfunction. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; complication: medical/metabolic; delayed graft function (DGF); graft survival; kidney disease; kidney transplantation/nephrology; liver allograft function/dysfunction; liver transplantation/hepatology

Mesh:

Year:  2015        PMID: 26663518     DOI: 10.1111/ajt.13527

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  21 in total

1.  Skin cancer in non-white liver transplant recipients: Mayo Clinic experience.

Authors:  Leila M Tolaymat; Danielle K Reimer; Joshua Feig; Melinda S Gillis; Leigh L Speicher; Claire B Haga; Emmanuel M Gabriel; Michael G Heckman; Mingyuan Yin; Scott W Fosko; Andrew P Keaveny; Nancy L Dawson
Journal:  Int J Dermatol       Date:  2021-03-20       Impact factor: 2.736

2.  Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.

Authors:  Vatche G Agopian; Michael P Harlander-Locke; Daniela Markovic; Wethit Dumronggittigule; Victor Xia; Fady M Kaldas; Ali Zarrinpar; Hasan Yersiz; Douglas G Farmer; Jonathan R Hiatt; Ronald W Busuttil
Journal:  JAMA Surg       Date:  2018-05-01       Impact factor: 14.766

Review 3.  Conceptual changes in small-for-size graft and small-for-size syndrome in living donor liver transplantation.

Authors:  Toru Ikegami; Jong Man Kim; Dong-Hwan Jung; Yuji Soejima; Dong-Sik Kim; Jae-Won Joh; Sung-Gyu Lee; Tomoharu Yoshizumi; Masaki Mori
Journal:  Korean J Transplant       Date:  2019-12-31

4.  Early Allograft Dysfunction Is Associated With Higher Risk of Renal Nonrecovery After Liver Transplantation.

Authors:  Hani M Wadei; David D Lee; Kristopher P Croome; Lorraine Mai; Deanne Leonard; Martin L Mai; C Burcin Taner; Andrew P Keaveny
Journal:  Transplant Direct       Date:  2018-03-14

5.  Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation.

Authors:  Chenlu Ni; Joe Masters; Ling Zhu; Weifeng Yu; Yingfu Jiao; Yuting Yang; Cui Cui; Suqing Yin; Liqun Yang; Bo Qi; Daqing Ma
Journal:  Trials       Date:  2020-06-26       Impact factor: 2.279

6.  A two-circular RNA signature of donor circFOXN2 and circNECTIN3 predicts early allograft dysfunction after liver transplantation.

Authors:  Kun Wang; Xuyong Wei; Qiang Wei; Di Lu; Wangyao Li; Binhua Pan; Junli Chen; Haiyang Xie; Shusen Zheng; Xiao Xu
Journal:  Ann Transl Med       Date:  2020-02

7.  Early Allograft Dysfunction Increases Hospital Associated Costs After Liver Transplantation-A Propensity Score-Matched Analysis.

Authors:  Simon Moosburner; Igor M Sauer; Frank Förster; Thomas Winklmann; Joseph Maria George Vernon Gassner; Paul V Ritschl; Robert Öllinger; Johann Pratschke; Nathanael Raschzok
Journal:  Hepatol Commun       Date:  2020-12-05

8.  Early prediction of acute kidney injury after liver transplantation by scoring system and decision tree.

Authors:  Wang Xin; Wang Yi; Hui Liu; Liu Haixia; Lin Dongdong; Yingmin Ma; Guangming Li
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

9.  Fluctuations of Estimated Glomerular Filtration Rate Outside Kidney Disease Improving Global Outcomes Diagnostic Criteria for Acute Kidney Injury in End-Stage Liver Disease Outpatients and Outcome Postliver Transplantation.

Authors:  Federica Fiacco; Fabio Melandro; Ilaria Umbro; Assunta Zavatto; Andrea Cappoli; Edoardo Poli; Stefano Ginanni Corradini; Manuela Merli; Francesca Tinti; Italo Nofroni; Pasquale B Berloco; Massimo Rossi; Anna Paola Mitterhofer
Journal:  Transplant Direct       Date:  2017-10-10

10.  Donor Hepatic Occult Collagen Deposition Predisposes to Peritransplant Stress and Impacts Human Liver Transplantation.

Authors:  Hirofumi Hirao; Takahiro Ito; Jerzy W Kupiec-Weglinski; Fady M Kaldas; Kentaro Kadono; Hidenobu Kojima; Bita V Naini; Kojiro Nakamura; Shoichi Kageyama; Ronald W Busuttil
Journal:  Hepatology       Date:  2021-08-30       Impact factor: 17.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.